ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 92909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 92909; 2) Community: the network communities that were significantly associated with the response to NSC 92909; 3) Molecule: the relationships between components within communities and NSC 92909; 4) MDR: the compounds that were significantly associated with the NSC 92909.

NSC Compound Enrichment Correlation
NSC 684902 Null 0.0273071169565318 0.3279657
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0273071169565318 0.35700502
NSC 701638 Null 0.0273071169565318 0.52920701
NSC 706995 Entinostat 0.0273071169565318 0.13039077
NSC 710546 Null 0.0273071169565318 -0.14813346
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0273071169565318 -0.036522043
NSC 731805 Null 0.0273071169565318 -0.0082731847
NSC 735846 Null 0.0273071169565318 0.32327767
NSC 736606 Null 0.0273071169565318 -0.17054549
NSC 749117 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline 0.0273071169565318 0.035354922
Total:37  Current:18    [First] [Prev] [Next] [Last]